Protective 'switch' in most common blood cancer opens new doors for diagnosis and treatment
Likely AI
A new study published in The Journal of Immunology by researchers at the Josep Carreras Leukaemia Research Institute (IJC) has uncovered a crucial biological "off switch" in diffuse large B cell lymphoma (DLBCL), the most common and one of the most aggressive forms of blood cancer. The findings reveal that a protein called HDAC7 plays a dual role: it is essential for building a healthy immune system, and when it goes missing in cancer cells, the disease becomes significantly more dangerous. Crucially, the team showed that restoring HDAC7 in cancer cells can slow or even stop tumor growth.
The Verdict
ClassificationLikely AI
ConfidenceHigh confidence
Analyzedtext, image
ImageAI Generated
Community Verdict
Sign in to vote
Be the first to vote on this assessment.
Embed Badge
Add this badge to your site to show the AI classification for this content.
[](https://real.press/content/b3953fd7-4750-4e30-8ff0-3ae12dc1e96a)